Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?

被引：2
作者：
Li, Dunhui [1 ,2 ,3 ]
Mastaglia, Frank L. [1 ,2 ]
Yau, Wai Yan [1 ]
Chen, Shengdi [4 ,5 ]
Wilton, Steve D. [1 ,2 ]
Akkari, Patrick A. [1 ,2 ,6 ]
机构：
[1] Univ Western Australia, Perron Inst Neurol & Translat Sci, 8 Verdun St, Nedlands, WA 6009, Australia
[2] Murdoch Univ, Ctr Mol Med & Innovat Therapeut, Murdoch, WA, Australia
[3] Zhengzhou Univ, Coll Nursing & Hlth, Zhengzhou, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Neurol, Sch Med, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Inst Neurol, Sch Med, Shanghai, Peoples R China
[6] Duke Univ, Dept Neurol, Durham, NC USA
来源：
MOVEMENT DISORDERS | 2022年 / 37卷 / 11期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1002/mds.29201
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：2184 / 2190
页数：7
相关论文
共 50 条
  • [21] RNA therapeutics: beyond RNA interference and antisense oligonucleotides
    Kole, Ryszard
    Krainer, Adrian R.
    Altman, Sidney
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (02) : 125 - 140
  • [22] RNA therapeutics: beyond RNA interference and antisense oligonucleotides
    Ryszard Kole
    Adrian R. Krainer
    Sidney Altman
    Nature Reviews Drug Discovery, 2012, 11 : 125 - 140
  • [23] Antisense Oligonucleotides As Potential Therapeutics for Type 2 Diabetes
    Chen, Suxiang
    Sbuh, Nabayet
    Veedu, Rakesh N.
    NUCLEIC ACID THERAPEUTICS, 2021, 31 (01) : 39 - 57
  • [24] Selective Suppression of α-Synuclein in Monoaminergic Neurons of Mice by Intranasal Delivery of Targeted Small Interfering RNA or Antisense Oligonucleotides: Potential Therapy for Parkinson's Disease
    Recasens, Ariadna
    Galofre, Mireia
    Carballo-Carbajal, Iria
    Ferres-Coy, A.
    Bove, Jordi
    Perier, Celine
    del Carmen Carmona, Maria
    Santos, M. I.
    Baena, S.
    Rosario Chica, M.
    Montefeltro, Andres P.
    Revilla, R.
    Bortolozzi, Analia
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S419 - S420
  • [25] Botanical Therapeutics for Parkinson's Disease
    LI Wen-wei
    Chinese Journal of Integrative Medicine, 2020, 26 (06) : 405 - 411
  • [26] Botanical Therapeutics for Parkinson’s Disease
    Wen-wei Li
    Chinese Journal of Integrative Medicine, 2020, 26 : 405 - 411
  • [27] Therapeutics in the neurorehabilitation of Parkinson's disease
    Colcher, A
    Stern, MB
    NEUROREHABILITATION AND NEURAL REPAIR, 1999, 13 (04) : 205 - 218
  • [28] Experimental therapeutics of Parkinson's disease
    Henderson, JM
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (11) : 841 - 844
  • [29] Botanical Therapeutics for Parkinson's Disease
    Li, Wen-wei
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2020, 26 (06) : 405 - 411
  • [30] Astrocytes and Therapeutics for Parkinson's Disease
    Rappold, Phillip M.
    Tieu, Kim
    NEUROTHERAPEUTICS, 2010, 7 (04) : 413 - 423
12345